483
Biokit, S.A.Biokit, S.A. – FDA 483, Jul 11, 2022
Record Details
An FDA inspection of Biokit S.A. in L'lissa D'Amunt (Barcelona), Spain, revealed significant quality system deficiencies. Observations included inadequate design verification failing to confirm design output meets input, a lack of established procedures to control non-conforming products, and the use of obsolete documents in active processes. These issues indicate a need for improved quality management practices at the device manufacturing facility.
View Company Profile
ID · 90eed3c7-47ad-41e8-9ea4-58ef736e6599
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.